Dr. Steve Beasley – Commercial Director
Steve has over 30 years experience gained from global pharmaceutical, biotechnology and chemical companies in both research and commercial fields.
Following cardiovascular drug discovery with Pfizer Central Research, he joined Shell Research Limited first in Natural Products chemistry and then in Organic Synthesis gaining his D.Phil under the supervision of Prof. Sir John Cornforth, FRS. Later he was first appointed Medicinal Chemistry group leader with Chiroscience R&D Ltd and led teams in autoimmune and inflammation research, and then Business Development Manager.
He was previously COO for De Novo Pharmaceuticals responsible for all research and commercial activity and most recently Chief Executive of the knowledge-base organisation, bioKneX. Steve joined Gentronix in 2007 and is responsible for the commercialisation of its technology and services.
He is a Chartered Chemist and Fellow of the Royal Society of Chemistry and a Member of the Institute of Directors.